Skip to content

AKV PHARMA

Active Private limited company (pre-2019)founded 2015active for 10 yearsKoolskampstraat 69, 8740 PittemKBO/BCE: BE 0644.617.062 subsidiary of HM Pharma
AKV PHARMA
Follow ReportCompare

Board

1 director, last change in May 2026
BV HM Pharma
Director, permanent representative Hanne Martens
since 01-04-2026
listed in the 2025 annual accounts, filed on 23-06-2026
Permanent representatives 1
Hanne Martens
Permanent representative, for BV HM Pharma
appointed by deed of 13-05-2026

Office holders in the KBO →

Mandates through the years

3 names, the dashed line is today
BV HM Pharma
Director
An-Katrien Vynckier
Director
VYNCKIER AnKatrien Tine Christiane
Board
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
  • BV HM Pharma
    • Director, since before 31-12-2025
  • An-Katrien Vynckier
    • Director, until 13-05-2026
  • VYNCKIER AnKatrien Tine Christiane
    • Board, from before 16-03-2023, no longer listed in the 2025 annual accounts

Control

Parent
HM Pharma
Equity €354,554
Profit €67,980 in 2026 (profit €73,689 in 2025)
Checked score 91
Source: accounts HM Pharma 31-03-2026
100%
This company
AKV PHARMA
Equity €52,420
Profit €25,201 in 2025

Capital

Contribution
€10,692.99
Source
2025 annual accounts

Articles of association

deed of 16-03-2023 (in Dutch)
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 April to 31 March

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure